Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease

Annals of Hematology

Volumn 83, Issue 7, 2004, Pages 441-443

  Hummel, Margit ^a   Hofheinz, Ralf ^a   Buchheidt, Dieter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chlamydia pneumoniae; Hodgkin's disease; Neutropenia

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BLEOMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; DACARBAZINE; DOXORUBICIN; FLUCONAZOLE; IMIPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; ROXITHROMYCIN; VANCOMYCIN; VINCRISTINE;

ADULT; ARTICLE; BRONCHOSCOPY; CANCER STAGING; CANDIDA ALBICANS; CASE REPORT; CHLAMYDOPHILA PNEUMONIAE; DISEASE SEVERITY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HODGKIN DISEASE; HUMAN; LEUKOPENIA; LUNG INFILTRATE; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; URINALYSIS;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZA COMPOUNDS; BLEOMYCIN; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DACARBAZINE; DOXORUBICIN; DRUG THERAPY, COMBINATION; FEMALE; HODGKIN DISEASE; HUMANS; IMIPENEM; IMMUNOCOMPROMISED HOST; NEUTROPENIA; PNEUMONIA, BACTERIAL; QUINOLINES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VANCOMYCIN; VINCRISTINE;

EID: 3042771627     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0799-6     Document Type: Article

References (9)

1. Balis E, Boufas A, Iliopoulos I, Legakis NJ, Zerva L (2003) Severe community-acquired pneumonia with acute hypoxemic respiratory failure due to primary infection with Chlamydia pneumoniae in a previously healthy adult. Clin Infect Dis 36:e155-e157
2. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR (2001) Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33:492-503
3. File TM Jr, Plouffe JF Jr, Breiman RF, Skelton SK (1999) Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia. Clin Infect Dis 29:426-428
4. Heinemann M, Kern WV, Bunjes D, Marre R, Essig A (2000) Severe Chlamydia pneumoniae infection in patients with neutropenia: case reports and literature review. Clin Infect Dis 31:181-184
5. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751
6. Kauppinen M, Saikku P (1995) Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis 21 [Suppl 3]:S244-S252
7. Kuo CC, Jackson LA, Campbell LA, Grayston JT (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451-461
8. Link H, Blumenstengel K, Bohme A, Cornely O, Kellner O, Nowrousian MR, Ostermann H, Schiel X, Wilhelm M (1999) Antimicrobial therapy for fever of unknown origin in neutropenia. Standard recommendations of the Working Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology (in German). Dtsch Med Wochenschr 124 [Suppl 1]:S3-S8
9. Zver S, Kozelj M, Cernelc P (1997) Chlamydia pneumoniae pneumonia with acute hemorrhagic pericarditis in patient with acute leukemia. Haematologica 82:254